[Tolvaptan, a vasopressin V<sub>2</sub> receptor antagonist, is the world's first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD)].

Yamada, Yoshihisa; Fujiki, Hiroyuki; Mizuguchi, Hiroshi; Takeshita, Yukinobu; Hattori, Katsuji; Ohmoto, Koji; Aihara, Miki; Nagano, Keisuke; Isakari, Yoshimasa; Yamamoto, Miho; Yamamura, Yoshitaka

[Tolvaptan, a vasopressin V₂ receptor antagonist, is the world's first approved drug for treatment of autosomal dominant polycystic kidney disease (ADPKD)].

Yamada, Yoshihisa; Fujiki, Hiroyuki; Mizuguchi, Hiroshi; Takeshita, Yukinobu; Hattori, Katsuji; Ohmoto, Koji; Aihara, Miki; Nagano, Keisuke; Isakari, Yoshimasa; Yamamoto, Miho; Yamamura, Yoshitaka.

Afiliação

Yamada Y; Department of Renal and Cardiovascular Research, Otsuka Pharmaceutical Co., Ltd.
Fujiki H; Department of Renal and Cardiovascular Research, Otsuka Pharmaceutical Co., Ltd.
Mizuguchi H; Department of Renal and Cardiovascular Research, Otsuka Pharmaceutical Co., Ltd.
Takeshita Y; Department of Renal and Cardiovascular Research, Otsuka Pharmaceutical Co., Ltd.
Hattori K; Department of Renal and Cardiovascular Research, Otsuka Pharmaceutical Co., Ltd.
Ohmoto K; Department of Medical Innovation, Otsuka Pharmaceutical Co., Ltd.
Aihara M; Medical Affairs, Otsuka Pharmaceutical Co., Ltd.
Nagano K; Scientific Partnering, Otsuka Pharmaceutical Co., Ltd.
Isakari Y; Pharmaceutical Planning Department, Otsuka Pharmaceutical Co., Ltd.
Yamamoto M; Regulatory Affairs Department, Otsuka Pharmaceutical Co., Ltd.
Yamamura Y; Pharmaceutical Business Division, Otsuka Pharmaceutical Co., Ltd.

Nihon Yakurigaku Zasshi ; 157(4): 254-260, 2022.

Article em Ja | MEDLINE | ID: mdl-35781456

Assuntos

Cistos; Rim Policístico Autossômico Dominante; Animais; Antagonistas dos Receptores de Hormônios Antidiuréticos/farmacologia; Antagonistas dos Receptores de Hormônios Antidiuréticos/uso terapêutico; AMP Cíclico/uso terapêutico; Cistos/tratamento farmacológico; Rim Policístico Autossômico Dominante/tratamento farmacológico; Tolvaptan/farmacologia; Tolvaptan/uso terapêutico; Vasopressinas/uso terapêutico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rim Policístico Autossômico Dominante / Cistos Limite: Animals Idioma: Ja Revista: Nihon Yakurigaku Zasshi Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google